Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-011510
Filing Date
2014-07-03
Accepted
2014-07-03 17:09:34
Documents
2
Period of Report
2014-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2265
2 ex-24karenling_poa.txt EX-24 4255
  Complete submission text file 0001179110-14-011510.txt   7933
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Issuer) CIK: 0001578845 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Ling Karen (Reporting) CIK: 0001597450 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55075 | Film No.: 14961451